前列腺增生症是泌尿外科常见病之一。据统计其发病率为38.3％。目前以激素或手术治疗为主。此类病人常伴有高血压、冠心病,不能耐受激素或手术治疗。因此,国内外学者都想探索一更理想的有效方法。Talwar 首先报告注射疗法治疗前列腺增生症,吴大兰等报告了注射疗法治疗前列腺增生症100例的疗效总结。我院自1978年1月以来对25例前列腺增生症进行了注射疗法治疗,同时对配方药物剂量进行了调整,取得了良好效果。 Prostatic hyperplasia is one of the common urological diseases. According to statistics, the incidence was 38.3%. Currently hormone-based or surgical treatment. Such patients often accompanied by hypertension, coronary heart disease, can not tolerate hormones or surgical treatment. Therefore, both domestic and foreign scholars want to explore a more ideal and effective method. Talwar first reported that injection therapy for benign prostatic hyperplasia, Wu Dalan and other reports of injection therapy for the treatment of benign prostatic hyperplasia in 100 cases of efficacy summary. In our hospital since January 1978 25 cases of benign prostatic hyperplasia were treated by injection therapy, while the dose of prescription drugs were adjusted and achieved good results.